AMA Recognized Myopia as Public Health Concern
The American Medical Association's recent move aims to improve vision care and insurance coverage for millions of Americans.
Updated on Sept. 25, 2026 in Asthma
Live Poll
Should myopia be officially classified as a disease to improve public health outcomes?
In June 2026, the American Medical Association (AMA) officially approved a resolution to recognize myopia as a significant public health concern. The move follows a 2024 consensus report from the National Academies of Sciences, Engineering, and Medicine recommending its classification as a disease.
Why it matters
Elevating myopia to a disease classification could fundamentally change how the condition is managed by expanding access to screenings and securing necessary insurance coverage for treatments. This shift addresses the increasing risk of vision-threatening complications like retinal detachment and glaucoma as prevalence rates rise.
A 2024 consensus report from the National Academies of Sciences, Engineering, and Medicine provides the clinical basis for this shift, noting that U.S. myopia prevalence has nearly doubled since the 1970s. Whether this classification will accelerate insurance coverage for current myopia-slowing therapies remains under investigation.
The players
American Medical Association
The national professional association that sets standards for medicine and health policy in the United States.
American Academy of Ophthalmology
The professional medical association representing ophthalmologists and advocating for global eye health.
National Academies of Sciences, Engineering, and Medicine
A private, nonprofit institution that provides independent, objective analysis to guide public health policy.
Centers for Medicare & Medicaid Services
The federal agency responsible for administering health insurance programs and setting national coverage policies.
World Health Organization
The specialized agency of the United Nations responsible for international public health monitoring and disease projections.
The details
Myopia occurs when the eye grows too long, causing light to focus in front of the retina rather than directly on it, which leads to blurred distance vision. By classifying it as a disease rather than a refractive error, the AMA seeks to normalize clinical interventions that slow axial elongation, such as low-dose atropine drops or specialized contact lenses. These treatments aim to prevent the eyeball from over-lengthening, thereby reducing the long-term risk of sight-threatening complications.
Timeline
1970s: The baseline period for current myopia prevalence tracking.
2021: The American Academy of Ophthalmology launched a formal myopia initiative.
2024: The National Academies of Sciences, Engineering, and Medicine issued its consensus report.
June 2026: The American Medical Association House of Delegates approved the resolution.
Late October 2026: An FDA advisory committee will review potential approval for atropine eyedrops.
Health Landscape
This resolution aligns with the 2024 National Academies of Sciences, Engineering, and Medicine consensus report, marking a formal shift toward treating myopia as a progressive health crisis rather than a simple need for corrective glasses. It signals a move to align clinical practice with long-term preventative care.
If you or your children have myopia, discuss the latest screening and management options with your eye care provider during your next visit. Early detection is critical, and you may want to ask if your current treatment plan aligns with emerging evidence regarding myopia-slowing therapies.
The takeaway
Myopia is a progressive condition that warrants proactive management to mitigate the risk of serious long-term vision loss. Talk to your optometrist or ophthalmologist about whether your current vision care includes strategies to slow axial elongation.
What happens next
An FDA advisory committee is scheduled to meet in late October 2026 to evaluate the broader approval of low-dose atropine eyedrops for myopia management.
Further reading
To understand more about how chronic conditions are managed, explore our guide to Asthma.
Source note: This article includes information reported by MedPage Today.
Live Poll
Should myopia be officially classified as a disease to improve public health outcomes?
